Company news

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Warren Buffett’s Berkshire Hathaway Inc. sold off its entire stake of WellPoint Inc. stock in the
first quarter, the firm reported Monday. Buffett’s firm owned more than 1.3 million shares of WellPoint—an Indianapolis-based
health insurer that has more than 432 million shares outstanding. His firm also disposed of its stake of nearly 1.2 million
shares in Minnesota-based UnitedHealth Group, another large health insurer. Berkshire Hathaway first invested in WellPoint
in the first quarter of 2007, spending nearly $80 million to acquire nearly 1 million shares. In the three years since, WellPoint
shares have lost 36 percent of their value. The company’s shares closed Monday at $53.52 apiece.

U.S. Health and Human Services Secretary Kethleen Sebelius came to Indianapolis Friday to award the Indiana University
School of Medicine
an $8.5 million federal grant to renovate a former research floor at Riley Hospital for Children.
The renovations, which are set to be completed in 2012, will enable the hospital to conduct pediatric clinical research trials
by adding 18,500 square feet of bio-storage and laboratory space. “Most drugs and diagnostics are tested in adults—but
children aren’t just little adults,” said Dr. Craig Brater, dean of the IU School of Medicine. The federal grant
is one of 146 American Recovery and Reinvestment Act construction awards, totaling $1 billion, given to build, repair and
renovate scientific research labs and related facilities nationwide.

Bioanalytical Systems Inc. narrowed its losses in its second quarter even though it suffered a 2-percent
drop in revenue. The West Lafayette-based contract research firm reported a $1.2 million loss in the period ended March 31,
compared with a $1.8 million loss reported for the same period last year. Revenue was down $200,000, to $6.9 million. Nearly
half of the loss came from $520,000 in expenses from staff reductions. Bioanalytical recently named Anthony S. Chilton as
president and CEO following the retirement of top executive Richard M. Shepperd earlier this year. Chilton, 53, had been Bioanalytical’s
chief operating officer since 2008.

Construction could begin as early as June 1 on a $225 million hospital in northern Indiana after the Porter County Plan Commission
approved the building plans, the Associated Press reported. Community Health Systems plans to build the five-story,
250-bed hospital at U.S. 6 and State Road 49. Porter hospital officials in Valparaiso say the last step to be completed is
an archaeological and bat survey.
 

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In